Report
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
| العنوان: | Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer |
|---|---|
| المؤلفون: | National Cancer Institute (NCI), Impact Therapeutics |
| المصدر: | A Phase 2 Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer |
| قاعدة البيانات: | ClinicalTrials.gov |
| الوصف غير متاح. |